Gastrointestinal Hemorrhage clinical trials
The registry lists 338 studies for Gastrointestinal Hemorrhage across more than 10 countries. 77 are recruiting or about to start. 233 of them are mainly about Gastrointestinal Hemorrhage (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12. Counting its narrower condition Peptic Ulcer Hemorrhage too: 388 studies, 83 open.
Get an email when these change. Save the Gastrointestinal Hemorrhage studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Chinese University of Hong Kong (17) · Assiut University (12) · AstraZeneca (6) · Changhai Hospital (4) · McMaster University (4) · Bayer (4) · Washington University School of Medicine (4) · Medtronic - MITG (4)
What is being tested here
Drugs under test in Gastrointestinal Hemorrhage studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Omeprazole | 2 | 2 | 5 |
| Tranexamic Acid | 1 | 2 | 7 |
| Metoclopramide | 1 | 2 | 4 |
| Vitamin K 1 | 1 | 0 | 2 |
| Warfarin | 1 | 0 | 2 |
| Aspirin | 1 | 0 | 2 |
| Chlorophyllin | 1 | 1 | 1 |
| Trimebutine | 1 | 1 | 1 |
| Fexuprazan | 1 | 0 | 1 |
| Fecal Microbiota Transplantation Capsule | 1 | 0 | 1 |
Drug classes tested here Proton pump inhibitors (PPIs) 3 open · Antiemetics 1 open
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest, phase 3 first
- Jun 2027Tegoprazan for Prevention of Gastrointestinal Complication in Ischemic Stroke Patients on Antiplatelet Therapy (TegoStroke) · Phase 3 · Hanyang University Guri Hospital
- Jun 2027Optimization Strategies for Blood Transfusion Protocols in the Emergency Treatment of Hemorrhagic Shock · Phase 3 · Xijing Hospital
- Sep 2027Trimebutine Maleate for Enhancing Gastric Visualization in Acute Upper Gastrointestinal Bleeding · Phase 3 · Assiut University
- Nov 2026Case-Specific Health Care Professional Clinical Survey for Concerto Versa™ Detachable Coils · Medtronic Endovascular
- Dec 2026Pediatric GI Endoscopy at Assiut University · Assiut University
- Dec 2026Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future · International Consortium of Circulatory Assist Clinicians
- Dec 2026How Often Does the Fecal Test for Occult Blood Turn Positive After Using Blood Thinners? · Jordan Collaborating Cardiology Group
- Jan 2027Acute Kidney Injury in Upper GI Bleeding Patients · Sohag University
- Mar 2027Anticoagulation After GI Bleeding Pilot Study and Registry · Ottawa Hospital Research Institute
- Mar 2027Hypofractionated Palliative Radiotherapy in Patients With Advanced Non-operable Rectal Cancer · Consorci Sanitari de Terrassa
Who these studies take
Of the 49 Gastrointestinal Hemorrhage studies recruiting now, 39 (80%) set no upper age limit and 4 (8%) stop at 75 or younger. 3 (6%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 5 (10%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 3 (6%) | 3 (6%) |
| 18 | 40 (82%) | 40 (82%) |
| 30 | 48 (98%) | 48 (98%) |
| 40 | 48 (98%) | 48 (98%) |
| 50 | 48 (98%) | 48 (98%) |
| 65 | 49 (100%) | 49 (100%) |
| 75 | 49 (100%) | 49 (100%) |
| 85 | 45 (92%) | 45 (92%) |
Across all 338 studies, recruiting or not: 14% stop at 75 or younger and 8% at 65; 14% take children; 0% are for women only and 1% for men only; 9% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Gastrointestinal Hemorrhage studies take
Of 73 interventional studies with no phase under Gastrointestinal Hemorrhage, half reached primary completion within 22 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Interventional, no phase | 22 mo8–38 · 73 studies | — | 26 mo10–42 · 63 studies |
| Observational | 36 mo23–82 · 47 studies | — | 35 mo23–63 · 42 studies |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 14, 2026.
Newly registered1
Studies
Recruiting first, then most recently updated. Showing 50 of 338. Browse all 338 → or search them.
- Randomized Trial of UI-EWD vs. Conventional Endoscopic Therapy for Nonvariceal Upper Gastrointestinal BleedingRecruitingNCT06188585Not applicable7 countries
- HISTOACRYL® Used for Embolization of Thoracoabdominal Artery BleedingNot yet recruitingNCT077530051 country
- Treatment Outcomes and Predictors After Endovascular Intervention for Portal Hypertension-Related Gastrointestinal Bleeding in CirrhosisRecruitingNCT079183781 country
- Fecal Microbiota Transplantation for Radiation-Induced ProctopathyRecruitingNCT06776029Phase 21 country
- OTSC vs. Angiographic Embolization in Patients With Refractory Non-variceal Upper Gastrointestinal BleedingRecruitingNCT04902248Not applicable3 countries
- Case-Specific Health Care Professional Clinical Survey for Concerto Versa™ Detachable CoilsEnrolling by invitationNCT076398531 country
- Evaluation of the Clinical Utility of Endoscopic Closure Using a Dual Action Tissue (DAT) ClipRecruitingNCT058524571 country
- Onyx™ Liquid Embolic IDE Clinical StudyRecruitingNCT06742801Not applicable1 country
- Detection of Blood in the GI Lumen With HemoPill AcuteRecruitingNCT07868068Not applicable1 country
- Anticoagulation After GI Bleeding Pilot Study and RegistryRecruitingNCT05290857Not applicable1 country
- A Study of Chlorophyllin or Placebo With Standard Treatment for Late Radiation Induced Luminal Gastrointestinal Tract BleedingNot yet recruitingNCT07837713Phase 31 country
- Gastrointestinal Bleeding in Critically Ill PatientsNot yet recruitingNCT07822958
- Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic TherapyRecruitingNCT04416581Phase 41 country
- Dietary Supplements to Treat Radiation-Induced Rectal InjuryRecruitingNCT06776016Phase 21 country
- Trimebutine Maleate for Enhancing Gastric Visualization in Acute Upper Gastrointestinal BleedingNot yet recruitingNCT07749300Phase 2/3
- A Disposable Endoscopic Closing Device Used for the Closure of Gastrointestinal TissueNot yet recruitingNCT07727564Not applicable
- Reducing Gastrointestinal Bleeding With Proton Pump Inhibitor Therapy in Acute Venous ThromboembolismRecruitingNCT06393868Phase 31 country
- Comprehensive HHT Outcomes Registry of the United States (CHORUS)RecruitingNCT062592921 country
- Tegoprazan for Prevention of Gastrointestinal Complication in Ischemic Stroke Patients on Antiplatelet Therapy (TegoStroke)RecruitingNCT07687706Phase 31 country
- Routine Use of Potassium Competitive Acid Blocker vs. Guideline-Directed Gastrointestinal Protection Strategy in Acute Myocardial InfarctionRecruitingNCT07467213Phase 31 country
- Marginal Ulcer Healing With Low-Thermal Argon Plasma Endoscopic TreatmentRecruitingNCT06543316Not applicable1 country
- A Study of a Urine Test to Detect Colorectal CancerRecruitingNCT076490574 countries
- Acute Kidney Injury in Upper GI Bleeding PatientsNot yet recruitingNCT076360831 country
- Algorithm-based Management to Reduce the Recurrence of GI Bleeding and Severe Epistaxis in Von Willebrand DiseaseRecruitingNCT06651255Not applicable1 country
- Video Capsule Endoscopy for Detection of Gastrointestinal Bleeding in the Small BowelRecruitingNCT059492681 country
- PillSense Use in Anemia and HemoccultEnrolling by invitationNCT069514901 country
- A Study to Evaluate the Performance of a Wireless Optical Sensor Capsule in Detection of UGIBRecruitingNCT06715293Not applicable1 country
- FENOX Trial (Comparative Effectiveness of Fexuprazan Co-therapy in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants)Not yet recruitingNCT07497893Not applicable1 country
- Capsule Endoscopy in GI Bleeding: A Retrospective StudyNot yet recruitingNCT07481591
- Hypofractionated Palliative Radiotherapy in Patients With Advanced Non-operable Rectal CancerRecruitingNCT038537331 country
- PPI Infusion Versus Oral Acid Pump Inhibitors for Bleeding Peptic UlcersRecruitingNCT05582174Phase 41 country
- Utilizing of Physiological Parameters Predict the Prognosis of Cirrhotic Patients With Gastrointestinal BleedingRecruitingNCT066805831 country
- Yiwei Jiaohuang Ointment for Gastrointestinal Bleeding Associated With Oral Antithrombotic AgentsNot yet recruitingNCT07339956Early Phase 11 country
- Management of Gastrointestinal Bleeding Under Direct Oral AnticoagulantsRecruitingNCT073331441 country
- How Often Does the Fecal Test for Occult Blood Turn Positive After Using Blood Thinners?Not yet recruitingNCT073278531 country
- Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the FutureRecruitingNCT060391761 country
- Is Cap Assisted Endoscopy Useful in Acute Upper Gastrointestinal Bleeding ?RecruitingNCT07268365Not applicable1 country
- Pediatric GI Endoscopy at Assiut UniversityNot yet recruitingNCT072399341 country
- TIPS for Complicated Portal Hypertension Related to Porto-Sinusoidal Vascular DiseaseRecruitingNCT071636891 country
- Validation of CAGIB Score for In-hospital Mortality of Cirrhotic Patients With Acute Gastrointestinal BleedingRecruitingNCT046629188 countries
- Hematological Disorders in Patients With GI AngiodysplasiaNot yet recruitingNCT07183995
- High Dose Oral Omeprazole in High Risk UGIBRecruitingNCT04394663Not applicable1 country
- Life-saving Treatment With Dry-plasma for Massive Bleeding in an Pre-hospital SettingNot yet recruitingNCT07012863Phase 4
- Clinical Characteristics, Etiologies, and Outcomes of Patients With Haematochezia at Al-Rajhi University Hospital.Not yet recruitingNCT07157228
- Transfusion Surveillance in AnaesthesiaRecruitingNCT064031631 country
- Optimization Strategies for Blood Transfusion Protocols in the Emergency Treatment of Hemorrhagic ShockNot yet recruitingNCT07129031Phase 31 country
- Gastrointestinal Bleeding is Blood Loss in the Digestive Tract, Classified as Upper or Lower. Ischemic Heart Disease is Due to Blocked Heart Arteries. Antiplatelet Drugs Help Prevent Heart Attacks But Increase GI Bleeding Risk, Especially When Used Together as Dual Therapy.Not yet recruitingNCT07125651
- HALP as a Novel Score for Prediction of Mortality and re_bleeding in Upper GIT BleedingNot yet recruitingNCT071140421 country
- Endoscopic Evaluation for Iron Deficiency Anemia in Patients on Antithrombotic TherapyRecruitingNCT07089030Not applicable1 country
- External Validation of the Glasgow-Blatchford Bleeding Score in a Tunisian PopulationRecruitingNCT070892771 country